Literature DB >> 30729426

CHRM2 Genotype Affects Inhibitory Control Mechanisms During Cognitive Flexibility.

Nicolas Zink1, Wiebke Bensmann1, Larissa Arning2, Ann-Kathrin Stock1, Christian Beste3.   

Abstract

The cholinergic system is one of the most important neurotransmitter systems, but knowledge about the relevance of the cholinergic muscarinergic receptor system for cognitive functions is still scarce. Evidence suggests that the cholinergic muscarinic 2 receptor (CHRM2) plays an important role in the processing of cueing/prior information that help to increase the efficacy of lower-level attentional processes. In the current study, we investigated whether this is also the case for higher-level cognitive flexibility mechanisms. To this end, we tested N = 210 healthy adults with a backward inhibition task, in which prior information needs to be used to guide cognitive flexibility mechanisms. Testing different polymorphisms of the CHRM2 gene, we found that variation in this gene play a role in cognitive flexibility. It could be demonstrated that rs8191992 TT genotype carriers are better able to suppress no longer relevant information and to use prior information for cognitive flexibility, compared to A allele carriers. We further found that rs2350780 GG genotype carriers performed worse than A allele carriers. The results broaden the relevance of the CHRM2 system for cognitive functions beyond attentional selection processes. Corroborating recent theories on the relevance of the cholinergic system for cognitive processes, these results suggest that CHRM2 is important to process of "prior information" needed to inform subsequent cognitive operations. Considering the importance of prior information for adaptive behavioral control, it is possible that CHRM2 also modulates other instances of higher-level cognitive processes as long as these require the processing of "prior information."

Entities:  

Keywords:  CHRM2; Choline; Cognitive flexibility; Genotype; Inhibition; Muscarinergic

Mesh:

Substances:

Year:  2019        PMID: 30729426     DOI: 10.1007/s12035-019-1521-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  57 in total

1.  Changing internal constraints on action: the role of backward inhibition.

Authors:  U Mayr; S W Keele
Journal:  J Exp Psychol Gen       Date:  2000-03

2.  Structure of the human M(2) muscarinic acetylcholine receptor gene and its promoter.

Authors:  C Zhou; A D Fryer; D B Jacoby
Journal:  Gene       Date:  2001-06-13       Impact factor: 3.688

3.  The role of response selection for inhibition of task sets in task shifting.

Authors:  Stefanie Schuch; Iring Koch
Journal:  J Exp Psychol Hum Percept Perform       Date:  2003-02       Impact factor: 3.332

4.  Current progress in schizophrenia research: cognitive phenotypes of schizophrenia: attention.

Authors:  James M Gold; Gunvant K Thaker
Journal:  J Nerv Ment Dis       Date:  2002-09       Impact factor: 2.254

Review 5.  Attention and executive deficits in Alzheimer's disease. A critical review.

Authors:  R J Perry; J R Hodges
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

6.  Muscarinic versus nicotinic modulation of a visual task. a pet study using drug probes.

Authors:  M J Mentis; T Sunderland; J Lai; C Connolly; J Krasuski; B Levine; J Friz; S Sobti; M Schapiro; S I Rapoport
Journal:  Neuropsychopharmacology       Date:  2001-10       Impact factor: 7.853

Review 7.  Acetylcholine in mind: a neurotransmitter correlate of consciousness?

Authors:  E Perry; M Walker; J Grace; R Perry
Journal:  Trends Neurosci       Date:  1999-06       Impact factor: 13.837

8.  The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment.

Authors:  R J Perry; P Watson; J R Hodges
Journal:  Neuropsychologia       Date:  2000       Impact factor: 3.139

9.  Sustained attention deficit in bipolar disorder.

Authors:  Luke Clark; Susan D Iversen; Guy M Goodwin
Journal:  Br J Psychiatry       Date:  2002-04       Impact factor: 9.319

10.  Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women.

Authors:  David E Comings; Sujihan Wu; M Rostamkhani; Matt McGue; William G Iacono; James P MacMurray
Journal:  Am J Med Genet       Date:  2002-07-08
View more
  3 in total

1.  Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma.

Authors:  Xiaoru Sun; Lu Wang; Hongkai Li; Chuandi Jin; Yuanyuan Yu; Lei Hou; Xinhui Liu; Yifan Yu; Ran Yan; Fuzhong Xue
Journal:  Aging (Albany NY)       Date:  2021-06-16       Impact factor: 5.682

2.  Association between genetic variants of the cholinergic system and postoperative delirium and cognitive dysfunction in elderly patients.

Authors:  Georg Winterer; Claudia D Spies; Maria Heinrich; Miriam Sieg; Jochen Kruppa; Peter Nürnberg; Peter H Schreier; Stefanie Heilmann-Heimbach; Per Hoffmann; Markus M Nöthen; Jürgen Janke; Tobias Pischon; Arjen J C Slooter
Journal:  BMC Med Genomics       Date:  2021-10-21       Impact factor: 3.063

Review 3.  The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review.

Authors:  Cody Slater; Yuxiang Liu; Evan Weiss; Kunpeng Yu; Qi Wang
Journal:  Brain Sci       Date:  2022-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.